statistiche ricercatore

Continente	#
NA - Nord America	993
AS - Asia	558
EU - Europa	390
SA - Sud America	91
Continente sconosciuto - Info sul continente non disponibili	20
AF - Africa	13
OC - Oceania	1
Totale	2.066

Nazione	#
US - Stati Uniti d'America	933
SG - Singapore	214
CN - Cina	133
IT - Italia	99
FI - Finlandia	87
BR - Brasile	77
BD - Bangladesh	58
HK - Hong Kong	57
DE - Germania	47
CA - Canada	35
VN - Vietnam	34
GB - Regno Unito	28
UA - Ucraina	27
PL - Polonia	23
FR - Francia	22
TR - Turchia	17
RU - Federazione Russa	16
IN - India	12
NL - Olanda	11
IE - Irlanda	10
MX - Messico	10
JP - Giappone	7
ZA - Sudafrica	6
CZ - Repubblica Ceca	5
AR - Argentina	4
ES - Italia	4
TW - Taiwan	4
VE - Venezuela	4
CR - Costa Rica	3
PK - Pakistan	3
PR - Porto Rico	3
AT - Austria	2
AZ - Azerbaigian	2
DZ - Algeria	2
EC - Ecuador	2
GE - Georgia	2
GT - Guatemala	2
HN - Honduras	2
ID - Indonesia	2
IQ - Iraq	2
IR - Iran	2
JM - Giamaica	2
LT - Lituania	2
MA - Marocco	2
NO - Norvegia	2
PY - Paraguay	2
SA - Arabia Saudita	2
AU - Australia	1
BE - Belgio	1
BO - Bolivia	1
CH - Svizzera	1
CO - Colombia	1
EG - Egitto	1
ET - Etiopia	1
GM - Gambi	1
GP - Guadalupe	1
IL - Israele	1
JO - Giordania	1
KZ - Kazakistan	1
LV - Lettonia	1
MN - Mongolia	1
MY - Malesia	1
NP - Nepal	1
PA - Panama	1
SE - Svezia	1
SK - Slovacchia (Repubblica Slovacca)	1
SV - El Salvador	1
UZ - Uzbekistan	1
Totale	2.046

Nome	#
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy	381
COVID-19 impact on consecutive neurological patients admitted to the emergency department	276
Where SUNCT Contacts TN: A Case Report	188
Onabotulinumtoxin-A: Previous Prophylactic Treatment Might Improve Subsequent Anti-CGRP Monoclonal Antibodies Response in Patients with Chronic Migraine	147
Un caso peculiare di ipertensione secondaria	137
Plasma levels of glial fibrillary acidic protein and neurofilament light chain in patients with chronic migraine: a multicenter case-control study	136
Un caso peculiare di ipertensione arteriosa secondaria.	130
An observational study on monoclonal antibodies against calcitonin-gene-related peptide and its receptor	107
Migraine Disability Improvement during Treatment with Galcanezumab in Patients with Chronic and High Frequency Episodic Migraine	103
Increased risk of functional neurological disorders following SARS‐CoV‐2 vaccination	95
Migraine Disability and Severity Improvement during Long-Term Treatment with Erenumab	88
Photophobia and migraine outcome during treatment with galcanezumab	72
Post COVID-19 vaccination headache: A clinical and epidemiological evaluation	70
CGRP-monoclonal antibodies and SARS-CoV-2 vaccination	69
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients	67
Totale	2.066

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	33	0	0	0	0	0	2	4	2	4	4	6	11
2022/2023	62	5	4	1	3	5	11	0	12	13	2	2	4
2023/2024	75	4	1	10	5	1	19	0	1	12	1	13	8
2024/2025	402	8	0	4	62	27	29	32	30	48	39	70	53
2025/2026	946	76	90	45	113	89	87	169	42	58	58	42	77
2026/2027	242	40	29	46	104	23	0	0	0	0	0	0	0
Totale													2.066